| 532.88 -4.29 (-0.8%) | 08-14 16:00 | |||||||||||||
|
|
| Short term | |
|||
| Mid term | ||||
| Targets | 6-month : | 646.68 | 1-year : | 755.32 |
| Resists | First : | 553.66 | Second : | 646.68 |
| Pivot price | 537.33 |
|||
| Supports | First : | 508.94 | Second : | 481.3 |
| MAs | MA(5) : | 539.53 |
MA(20) : | 529.77 |
| MA(100) : | 447.61 |
MA(250) : | 441.63 |
|
| MACD | MACD : | 15 |
Signal : | 17.8 |
| %K %D | K(14,3) : | 67.6 |
D(3) : | 73.7 |
| RSI | RSI(14): 58.9 |
|||
| 52-week | High : | 553.66 | Low : | 364.71 |
Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.[ CHE ] has closed above bottom band by 40.0%. Bollinger Bands are 6.8% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 539.95 - 543.02 | 543.02 - 546.35 |
| Low: | 519.97 - 523.38 | 523.38 - 527.08 |
| Close: | 526.43 - 532.38 | 532.38 - 538.83 |
Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, doctors, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates through two segments: VITAS and Roto-Rooter segments. The company offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees. The company also provides direct medical services to patients, as well as spiritual and emotional counseling to both patients and their families. Chemed Corporation was incorporated in 1970 and is headquartered in Cincinnati, Ohio.
Tue, 11 Aug 2026
Royal Bank of Canada Sells 18,419 Shares of Chemed Corporation $CHE - marketbeat.com
Mon, 10 Aug 2026
Chemed Corp (CHE) legal chief exercises 6,786 options, withholds 5,878 shares - stocktitan.net
Mon, 10 Aug 2026
Chemed Corp (CHE) Stock Analysis: Navigating High Valuation with Sustainable Growth Potential - DirectorsTalk Interviews
Mon, 10 Aug 2026
Chemed Corporation $CHE Shares Sold by Quantinno Capital Management LP - marketbeat.com
Thu, 06 Aug 2026
Chemed Corporation Declares Quarterly Dividend of 70 Cents - Yahoo Finance
Wed, 05 Aug 2026
Amundi Raises Stock Position in Chemed Corporation $CHE - marketbeat.com
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Outperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Outperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NYSE
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Care Facilities
|
|
| Shares Out | 13 (M) |
| Shares Float | 13 (M) |
| Held by Insiders | 1.9 (%) |
| Held by Institutions | 109.3 (%) |
| Shares Short | 566 (K) |
| Shares Short P.Month | 602 (K) |
| EPS | 19.89 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 63.81 |
| Profit Margin | 10.6 % |
| Operating Margin | 13.2 % |
| Return on Assets (ttm) | 13.4 % |
| Return on Equity (ttm) | 27.1 % |
| Qtrly Rev. Growth | 8.8 % |
| Gross Profit (p.s.) | 65.74 |
| Sales Per Share | 198.92 |
| EBITDA (p.s.) | 31.89 |
| Qtrly Earnings Growth | 43.7 % |
| Operating Cash Flow | 390 (M) |
| Levered Free Cash Flow | 308 (M) |
| PE Ratio | 26.77 |
| PEG Ratio | 2.2 |
| Price to Book value | 8.35 |
| Price to Sales | 2.67 |
| Price to Cash Flow | 17.86 |
| Dividend | 0.6 |
| Forward Dividend | 0 |
| Dividend Yield | 0.1% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |